the Illinois State Employees Group Insurance Program · Zepbound and Wegovy coverage

Does the Illinois State Employees Group Insurance Program cover Zepbound or Wegovy?

Last updated

Covered when medically necessary for adults with obesity, by state law since July 2024.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Covered when medically necessary for adults with obesity, by state law since July 2024. Every health plan in Illinois' State Employees Group Insurance Program covers medically necessary injectable weight-loss medication for adults with obesity, prediabetes or gestational diabetes, from July 1, 2024. In its words: "Effective July 1, 2024, per 5 ILCS 375/6.11c, all health plans under the State Employees Group Insurance Program will provide coverage for all types of medically necessary injectable medication prescribed to improve glucose or weight loss for use by adults (age 18 and over) that have been diagnosed with prediabetes, gestational diabetes, or obesity." (Illinois Department of Central Management Services, State Employee Benefits, Summary of Benefits and Coverage, cms.illinois.gov, Jul 1, 2024, read Nov 19, 2026). To stay covered, the treatment must remain medically necessary and members may be asked to join a lifestyle management plan. In its words: "To continue to qualify for coverage under this Section, the continued treatment must be medically necessary, and covered members must, if given advance, written notice, participate in a lifestyle management plan administered by their health plan." (5 ILCS 375/6.11C, Illinois Compiled Statutes, ilga.gov/legislation/ilcs/documents/000503750K6.11C.htm, read Nov 19, 2026).

Questions

the Illinois State Employees Group Insurance Program, Zepbound and Wegovy: common questions

Does the Illinois State Employees Group Insurance Program cover Zepbound for weight loss?

Covered when medically necessary for adults with obesity, by state law since July 2024. Every health plan in Illinois' State Employees Group Insurance Program covers medically necessary injectable weight-loss medication for adults with obesity, prediabetes or gestational diabetes, from July 1, 2024. In its words: "Effective July 1, 2024, per 5 ILCS 375/6.11c, all health plans under the State Employees Group Insurance Program will provide coverage for all types of medically necessary injectable medication prescribed to improve glucose or weight loss for use by adults (age 18 and over) that have been diagnosed with prediabetes, gestational diabetes, or obesity." (Illinois Department of Central Management Services, State Employee Benefits, Summary of Benefits and Coverage, cms.illinois.gov, Jul 1, 2024, read Nov 19, 2026). To stay covered, the treatment must remain medically necessary and members may be asked to join a lifestyle management plan. In its words: "To continue to qualify for coverage under this Section, the continued treatment must be medically necessary, and covered members must, if given advance, written notice, participate in a lifestyle management plan administered by their health plan." (5 ILCS 375/6.11C, Illinois Compiled Statutes, ilga.gov/legislation/ilcs/documents/000503750K6.11C.htm, read Nov 19, 2026). Zepbound not covered: the cash price at your dose

Does the Illinois State Employees Group Insurance Program cover Wegovy for weight loss?

Covered when medically necessary for adults with obesity, by state law since July 2024. Every health plan in Illinois' State Employees Group Insurance Program covers medically necessary injectable weight-loss medication for adults with obesity, prediabetes or gestational diabetes, from July 1, 2024. In its words: "Effective July 1, 2024, per 5 ILCS 375/6.11c, all health plans under the State Employees Group Insurance Program will provide coverage for all types of medically necessary injectable medication prescribed to improve glucose or weight loss for use by adults (age 18 and over) that have been diagnosed with prediabetes, gestational diabetes, or obesity." (Illinois Department of Central Management Services, State Employee Benefits, Summary of Benefits and Coverage, cms.illinois.gov, Jul 1, 2024, read Nov 19, 2026). To stay covered, the treatment must remain medically necessary and members may be asked to join a lifestyle management plan. In its words: "To continue to qualify for coverage under this Section, the continued treatment must be medically necessary, and covered members must, if given advance, written notice, participate in a lifestyle management plan administered by their health plan." (5 ILCS 375/6.11C, Illinois Compiled Statutes, ilga.gov/legislation/ilcs/documents/000503750K6.11C.htm, read Nov 19, 2026). Wegovy not covered: the cash price at your dose

What do Zepbound and Wegovy cost if the Illinois State Employees Group Insurance Program does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership) among sellers that serve Illinois; compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership) among sellers that serve Illinois. Every GLP-1's cash price without insurance

Does Medicaid cover Zepbound or Wegovy?

It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.